Front Line Medical Counts On Fast UK Access For COBRA-OS REBOA Device

Aortic Occlusion Device Maker Plans To Capitalize On UK Prehospital System

The UK's established emergency care prehospital system potentially opens up a faster route to market for Front Line Medical Technologies's aortic occlusion device, COBRA-OS. Asha Parekh, Front Line CEO, talks to Medtech Insight about the company's different strategic approach to UK market access in comparison to North America.

London, UK
Front Line Medical Technologies Launches COBRA-OS REBOA Device In The UK (Shutterstock)

More from Market Access

More from Strategy